Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1155/2018/5638283 | ||||
| Año | 2018 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Purpose. To compare multiparametric (mp) FDG-PET/MRI metrics between hepatocellular carcinoma (HCC) and liver parenchyma and to assess the correlation between mpMRI and FDG-PET standard uptake values (SUVs) in liver parenchyma and HCC. Methods. This prospective, institutional review board-approved study enrolled 15 patients (M/F 12/3; mean age 61 y) with HCC. mpMRI including blood-oxygen-level-dependent (BOLD) MRI, intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI), and dynamic contrast-enhanced-(DCE-) MRI was performed simultaneously with F-18-FDG-PET on a 3T PET/MRI hybrid system. Quantitative BOLD, IVIM and DCE-MRI parameters (Tofts model (TM) and shutter-speed model (SSM)), and PET parameters (SUVmean and SUVmax) were quantified and compared between HCC lesions and liver parenchyma using Wilcoxon signed-rank tests. SUV ratios between HCCs and liver were also calculated (SUVmean T/L and SUVmax T/L). Diagnostic performance of (combined) mp-PET/MRI parameters for characterization of HCC was assessed using ROC analysis. Spearman correlations between PET and mpMRI parameters in HCC tumors and liver parenchyma were evaluated. Results. 21 HCC lesions (mean size 4.0 +/- 2.4 cm; range 2-13 cm) were analyzed. HCCs exhibited significantly higher arterial fraction (from DCE-MRI) and lower R-2* pre-O-2 and post-O-2 (from BOLD-MRI) versus liver parenchyma (P < 0.032). The highest diagnostic performance for differentiation between HCC and liver parenchyma was achieved for combined ART SSM and R-2* post-O-2 (AUC=0.91). SUVmax showed reasonable performance for differentiation of HCC versus liver (AUC. 0.75). In HCC, DCE-MRI parameters K-trans (TM and SSM) and v(e) TM exhibited significant negative correlations with SUVmax T/L (r ranges from -0.624 to -0.566; FDR-adjusted P < 0.050). Conclusions. Despite the observed reasonable diagnostic performance of FDG-PET SUVmax for HCC detection and several significant correlations between FDG-PET SUV and DCE-MRI parameters, FDG-PET did not provide clear additional value for HCC characterization compared to mpMRI in this pilot study.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Hectors, Stefanie | Mujer |
Icahn Sch Med Mt Sinai - Estados Unidos
Icahn School of Medicine at Mount Sinai - Estados Unidos Sorbonne Université - Francia |
| 2 | Wagner, Mathilde | Mujer |
Icahn Sch Med Mt Sinai - Estados Unidos
Sorbonne Univ - Francia Icahn School of Medicine at Mount Sinai - Estados Unidos Sorbonne Université - Francia |
| 3 | BESA-CORREA, CECILIA | Mujer |
Icahn Sch Med Mt Sinai - Estados Unidos
Pontificia Universidad Católica de Chile - Chile Icahn School of Medicine at Mount Sinai - Estados Unidos |
| 4 | Huang, Wei | - |
Oregon Hlth & Sci Univ - Estados Unidos
Oregon Health & Science University - Estados Unidos |
| 5 | Taouli, Bachir | Hombre |
Icahn Sch Med Mt Sinai - Estados Unidos
Icahn School of Medicine at Mount Sinai - Estados Unidos |
| Fuente |
|---|
| National Cancer Institute |
| Bayer Corporation |
| Fondation ARC |
| Fondation ARC pour la Recherche sur le Cancer |
| Guerbet |